Investigation of Metabolite Profile of YM758, a Novel If Channel Inhibitor

Naoyuki Nakada1

  • 1Analysis and Pharmacokinetics Research Laboratories, Drug Discovery Research, Astellas Pharma Inc., Miyukigaoka 21, Tsukuba, Ibaraki, 305-8585, Japan. naoyuki.nakada@astellas.com.

Drugs in R&D
|March 31, 2016
PubMed
Abstract